Search
Now showing items 1-4 of 4
Use of Real-World Evidence for Healthcare Decision Making in the Middle East: Practical Considerations and Future Directions.
(2019)
Introduction:
Real-world evidence (RWE) is increasingly being used in coverage, reimbursement and formulary decisions for medicines globally.
Areas covered:
The Middle East (ME) region is significantly behind in ...
Impact of Dual versus Single Antiplatelet Therapy on Major Cardiovascular Outcomes in Patients with Acute Coronary Syndrome in the Arabian Gulf
(2019)
Objective:
To evaluate the association of dual versus single antiplatelet therapy with major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) in the Arabian Gulf. Subjects and Methods: ...
Premature Myocardial Infarction in the Middle East and North Africa: Rationale for the Gulf PREVENT Study
(2019-05)
Abstract:
The Middle East and North Africa (MENA) region has a high burden of morbidity and mortality due to premature ( 55 years in men; 65 years in women) myocardial infarction (MI) and acute coronary syndrome (ACS). ...
Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions
(2019)
Introduction:
Real-world evidence (RWE) is increasingly being used in coverage, reimbursement and formulary decisions for medicines globally.
Areas covered:
The Middle East (ME) region is significantly behind in ...